Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...
February is American Heart Month. And what better time to talk about heart health? Did you know heart disease claims a life ...
I will admit it - I fell for the promise of diet drinks. A few years ago, when I was trying to get healthier, I switched from ...
A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...
Divorce can be painful for children of separating parents, but new research out of the University of Texas at Arlington ...
A new Georgetown University Medical Center study in collaboration with MedStar Health and the National Institutes of Health exploring a new brain imaging technique is bringing stroke experts a step ...
Older adults who are admitted to the hospital with their first ischemic stroke who have poor nutritional status upon admission have a higher risk of post-stroke myocardial injury, a study shows.
Johnson & Johnson MedTech issued a recall for its Biosense Webster Varipulse Bi-Directional Ablation Catheter following reports of strokes and transient ischemic attacks in patients undergoing ...
FDA approval was based on the AcT noninferiority trial that found tenecteplase (at 0.25 mg/kg) to be at least on par with alteplase for safety and efficacy in acute ischemic stroke in Canadians ...
In recognition of Brain Health Awareness Week, which runs from March 10-16, Jamaica Hospital Medical Center Neurosurgeon Dr.
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback